YARD-FORCE
31.1.2024 02:51:31 CET | Business Wire | Press release
Yard Force takes a bold step forward with the introduction of the REVOLA robot lawn mower, challenging the norm in the Outdoor Power Equipment (OPE) market, with fully-featured and Virtual Boundary Technology. Recent data from Statista reveals that the OPE market reached a staggering $33.56 billion in 2022, with an anticipated Compound Annual Growth Rate (CAGR) of 5.6% from 2022 to 2027, projecting a market size of $44.07 billion. Lawn mowers, especially those integrating lithium-ion technology, are at the forefront of this growth, boasting an estimated CAGR of 9%, outpacing other OPE categories.
The REVOLA robot lawn mower from Yard Force emerges as a game-changer, not just as an efficient grass-cutting tool but as a solution to longstanding challenges in the industry. Packed with advanced technologies, the REVOLA promises users a unique and efficient lawn-mowing experience.
Key Features of the REVOLA Robot Lawn Mower:
1. Virtual Boundary Navigation System: The Virtual Boundary Navigation System in the REVOLA is called APNT (Advanced Positioning and Navigation Technology) leverages a multi-faceted approach to ensure accurate and reliable navigation. It utilizes satellite positioning for global location awareness, path planning algorithms for efficient route optimization, ultrasonic sensor for proximity sensing, and VSLAM (Visual Simultaneous Localization and Mapping) technology for real-time visual mapping and positioning. The VSLAM technology is a standout feature, allowing the REVOLA to create a dynamic map of its surroundings, navigate with precision, and adapt to changes in the environment. This technology plays a crucial role in overcoming obstacles, providing flexibility, and ensuring a robust navigation experience even in challenging conditions.
2. Addressing Existing Pain Points: The REVOLA addresses common challenges faced by traditional virtual boundary robot mowers. Unlike its counterparts, the REVOLA's VSLAM technology enables it to accurately cutting even though satellite signal is weak. Additionally, positioning inaccuracies caused by obstacles such as trees, houses, or electric poles are mitigated through the advanced VSLAM technology. This results in a seamless and trouble-free mowing experience for users, eliminating the frustrations associated with traditional navigation limitations.
3. Enhanced Safety Features: Safety is a top priority for the REVOLA, as validated by TÜV Rheinland tests. Traditional satellite-based mowers may face challenges with larger stones, potentially causing damage to blades or posing risks to objects like water pipes and toys. The REVOLA mitigates these risks through its intelligent obstacle recognition and detection system by integrated ultrasonic sensor and RGB camera. This system ensures that the mower can identify obstacles, including stones larger than 10 cm, and take appropriate actions to navigate around them, promoting a safe mowing process and protecting both the mower and the surrounding environment.
4. Optimized Battery Consumption Performance: The REVOLA is designed for efficient and long-lasting performance with its optimized battery consumption thanks to the systematic cut algorithm. Equipped with a powerful 28V 5.7Ah battery, the high-efficiency brushless motor further enhances efficiency, operating at optimal speeds of revolutions per minute (RPM) to ensure precise grass cutting. This combination of a high-capacity battery and a high- efficiency brushless motor contributes to the REVOLA's effectiveness in maintaining lawns while maximizing battery life.
5. Smart Connectivity: Smart Connectivity is a key aspect of the REVOLA, providing users with remote control and monitoring capabilities. The mower is equipped with Bluetooth, 4G, and Wi-Fi connectivity, ensuring comprehensive network coverage. Users can leverage the dedicated app to monitor the mower's progress from anywhere, allowing for real-time tracking of mowing activities. This connectivity not only enhances user convenience but also allows for more personalized and efficient lawn care based on specific preferences and needs.
6. RGB Recognition: RGB recognition in the REVOLA involves the use of Red, Green, and Blue color channels to identify and differentiate various elements within the lawn. The mower employs a sophisticated camera that captures images of the lawn. By analyzing the color spectrum and structure of the grass, the REVOLA can distinguish between different types of vegetation, ensuring a more targeted and efficient mowing process. This feature allows the mower to adapt its mowing pattern based on the specific characteristics of the lawn, resulting in a more precise and customized cutting experience.
7. OTA (Over the Air) Updates: The OTA update capability of the REVOLA enables the mower to receive software updates and enhancements remotely, without requiring manual intervention. This feature ensures that the REVOLA remains current with the latest technological developments, performance optimizations, and bug fixes. Manufacturers can regularly release updates to improve the mower's functionality, address any identified issues, or introduce new features. Users can conveniently download and install these updates over the air, ensuring that their REVOLA mower continues to operate at its best without the need for physical updates or visits to a service center.
Future Outlook and Industry Impact:
As the OPE market continues to evolve, the REVOLA robot lawn mower positions itself as a revolutionary product. Its advanced VSLAM technology, coupled with a user-friendly design, addresses longstanding industry challenges and paves the way for the future of intelligent lawn management. Yard Force's commitment to innovation and excellence sets the REVOLA apart, making it a frontrunner in reshaping the landscape of outdoor power equipment.
About Yard Force:
Yard Force is a world recognized brand dedicated to providing innovative outdoor power equipment solutions. With a focus on cutting-edge technology and user-friendly designs, Yard Force aims to transform the lawn care experience for users worldwide.
Follow Yard Force:
- Website: https://www.yardforce.eu
- Facebook: https://www.facebook.com/YardForceEurope
*Note: The information provided in this press release is based on data available as of Jan 23rd, 2024. Any future developments or changes may not be reflected in this release. *
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240130520868/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom